| |
PRZOOM - /newswire/ -
Cologne, North Rhine-Westphalia, Germany, 2025/03/10 - Specialty chemicals company LANXESS is introducing Lewatit MDS TP 108, a new ion exchange resin for removing short-chain fluorinated components (PFAS) from water - LANXESS.com. FRA: DE Frankfurt: LXS
|
| |
• Efficient water treatment for sustainable products;
• Significantly more effective than activated carbon adsorption;
• Twice the service life, reduced material and disposal costs.
These PFAS, with three or fewer carbon atoms, are the smallest members of this substance class and are often the most difficult to remove during water treatment. The new product also enables users to save a considerable amount of material and disposal costs, because it lasts about twice as long as conventional ion exchange resins or alternative technologies such as activated carbon adsorption.
“With Lewatit MDS TP 108, we are setting new standards in water treatment and ideally complement our product portfolio for the removal of PFAS. At the same time, we help to protect water as a valuable resource,” says Dr. Dirk Steinhilber, Application Technology Manager in the LANXESS Liquid Purification Technologies business unit.
About LANXESS
LANXESS (lanxess.com) is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,400 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
|
michael.fahrig[.]lanxess.com 
